XML 78 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) A summary of changes in the balances of each component of accumulated other comprehensive loss, net of tax, follows:
Defined Benefit PlansTranslation AdjustmentTotal
Balance at January 1, 2022$(398)$10 $(388)
Amounts arising during the perioda,b
61 — 61 
Amounts reclassifiedc
7 — 7 
Balance at December 31, 2022(330)10 (320)
Amounts arising during the perioda,b
41 — 41 
Amounts reclassifiedc
5 — 5 
Balance at December 31, 2023(284)10 (274)
Amounts arising during the perioda,b
(44)— (44)
Amounts reclassifiedc
4 — 4 
Balance at December 31, 2024$(324)$10 $(314)
a.Includes net actuarial gains (loss), net of noncontrolling interest, totaling $59 million for 2022, $38 million for 2023 and $(46) million for 2024.
b.Includes tax benefits totaling $2 million for 2022, 2023 and 2024.
c.Includes amortization primarily related to actuarial losses, net of taxes of less than $1 million for 2022, 2023 and 2024.
Compensation costs charged against earnings Compensation cost charged against earnings for stock-based awards for the years ended December 31 follows:
202420232022
Selling, general and administrative expenses$65 $64 $57 
Production and delivery44 45 38 
Total stock-based compensation109 109 95 
Tax benefit and noncontrolling interests’ sharea
(4)(5)(4)
Impact on net income$105 $104 $91 
a. Charges in the U.S. are not expected to generate a future tax benefit.
Summary of stock options and SARs outstanding and changes during the period
A summary of stock options outstanding as of December 31, 2024, and activity during the year ended December 31, 2024, follows:
Number of
Options		Weighted-
Average
Exercise Price
Per Share		Weighted-
Average
Remaining
Contractual
Term (years)		Aggregate
Intrinsic
Value
Balance at January 18,749,933 $15.63 
Exercised(3,140,886)18.13 
Balance at December 315,609,047 14.22 4.1$134 
Vested and exercisable at December 315,609,047 14.22 4.1$134 
Summary Of Outstanding Stock-settled RSUs and PSUs A summary of outstanding stock-settled RSUs and PSUs as of December 31, 2024, and activity during the year ended December 31, 2024, follows:
Number of AwardsWeighted-Average Grant-Date Fair Value Per AwardAggregate
Intrinsic
Value
Balance at January 15,699,575 $37.23  
Granted2,262,830 39.46  
Vested(2,224,239)34.37  
Forfeited(15,082)41.00  
Balance at December 315,723,084 39.21 $218 
Summary of Outstanding Cash-Settled RSUs and PSUs A summary of outstanding cash-settled RSUs as of December 31, 2024, and activity during the year ended December 31, 2024, follows:
Number of AwardsWeighted-Average Grant-Date Fair Value Per AwardAggregate
Intrinsic
Value
Balance at January 1858,741 $40.23  
Granted626,050 39.58 
Vested(398,727)38.19 
Forfeited(22,578)40.72  
Balance at December 311,063,486 40.60 $40 
Cash Proceeds Received and Tax Benefit from Share-based Payment Awards The following table includes amounts related to exercises of stock options and vesting of RSUs and PSUs during the years ended December 31:
 202420232022
FCX shares tendered or withheld to pay the exercise   
price and/or the statutory withholding taxesa
1,505,675 1,633,519 1,511,072 
Cash received from stock option exercises$29 $47 $125 
Actual tax benefit realized for tax deductions$5 $4 $13 
Amounts FCX paid for employee taxes$35 $50 $55 
a.Under terms of the related plans, upon exercise of stock options, vesting of stock-settled RSUs and payout of PSUs, employees may tender or have withheld FCX shares to pay the exercise price and/or required withholding taxes.